Supernus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $56.23 |
Previous Close | $55.75 |
Day Range | $53.55-$56.59 |
52W Range | $29.16-$59.68 |
Market Cap | $3.1B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $718.9M |
Revenue Growth (YoY) | 21.5% |
Gross Profit (12 Mos) | $538.1M |
Diluted EPS | -$0.34 |
News
See moreYahoo Finance • 4 days ago
Supernus Pharmaceuticals to Participate in March Investor Conferences
Yahoo Finance • 2 months ago
Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back
Yahoo Finance • 3 months ago
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
Yahoo Finance • 3 months ago
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
About
CEO | Mr. Jack A. Khattar M.B.A. |
CFO | Mr. Timothy C. Dec |
Address | 9715 Key West Avenue, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 674 |
